In a report from Kommersant, information from the analytics agency DSM Group confirmed a 16.8 per cent enhance year-on-year in mood-boosting medicine, which exceeded the overall gross sales of antidepressants for all of 2023 (15.3 million packages).
Throughout the first 11 months of 2024, the gross sales additionally surpassed the earlier excessive of 13 million packages bought in 2022.
Extra folks in Russia are taking antidepressants now than earlier than Russia’s full-scale invasion of Ukraine in late February 2022.
Amitriptyline, fluoxetine and Zoloft are the three hottest antidepressants in Russia, and Zoloft gross sales surged by 300% to 1.7 million packages in 2024 after returning to Russian pharmacy cabinets.
The US and EU sanctions on pharmaceutical and medical system exports influence provides of the medicine, with Russian pharmacies and distributors persevering with to face shortages of the medicine as a consequence of each excessive demand and sanctions.
Shockingly, in only one week, from February 28 to March 6, 577,600 packages of antidepressants have been bought for a complete of 525.6 million rubles ($5.1 million).
A report from The Heart for the Improvement of Superior Applied sciences revealed that Russians spent 70 per cent extra on antidepressants within the first 9 months of 2022 than in comparison with the identical interval in 2021, whereas the variety of packages bought elevated by 48 per cent, with 8.4 million bought throughout that point.
,
#Antidepressant #gross sales #Russia #hit #report #excessive #battle #Ukraine #continues,
https://cdn-images.the-express.com/img/dynamic/12/1200×630/316499.jpg ,
